Free Trial

Cronos Group Q4 2022 Earnings Report

Cronos Group logo
$1.97 +0.03 (+1.55%)
As of 02/21/2025 04:00 PM Eastern

Cronos Group EPS Results

Actual EPS
-$0.14
Consensus EPS
-$0.05
Beat/Miss
Missed by -$0.09
One Year Ago EPS
N/A

Cronos Group Revenue Results

Actual Revenue
$22.89 million
Expected Revenue
$21.35 million
Beat/Miss
Beat by +$1.54 million
YoY Revenue Growth
N/A

Cronos Group Announcement Details

Quarter
Q4 2022
Time
N/A

Conference Call Resources

Conference Call Audio

Cronos Group Earnings Headlines

Cronos Group And 2 Other TSX Penny Stocks To Consider
Alert: DOGE goes live
"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what he might do next. And one widely followed Boston based think tank is stepping forward with their official playbook.
Cronos Australia Ltd. Reduces Stake in Vitura Health
See More Cronos Group Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cronos Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cronos Group and other key companies, straight to your email.

About Cronos Group

Cronos Group (NASDAQ:CRON) operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

View Cronos Group Profile

More Earnings Resources from MarketBeat